188 related articles for article (PubMed ID: 30154881)
1. The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients.
Kadri AN; Kaw R; Al-Khadra Y; Abuamsha H; Ravakhah K; Hernandez AV; Tang WHW
Arch Med Sci; 2018 Aug; 14(5):1003-1009. PubMed ID: 30154881
[TBL] [Abstract][Full Text] [Related]
2. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
[TBL] [Abstract][Full Text] [Related]
3. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
[TBL] [Abstract][Full Text] [Related]
4. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients.
Park S; Cho GY; Kim SG; Hwang YI; Kang HR; Jang SH; Kim DG; Song YR; Bae YA; Jung KS
Crit Care; 2009; 13(3):R70. PubMed ID: 19445682
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in clinical characteristics and long-term outcome in acute decompensated heart failure patients with preserved and reduced ejection fraction.
Nakada Y; Kawakami R; Nakano T; Takitsume A; Nakagawa H; Ueda T; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Okura H; Saito Y
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(7):H813-20. PubMed ID: 26747499
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.
Steg PG; Joubin L; McCord J; Abraham WT; Hollander JE; Omland T; Mentré F; McCullough PA; Maisel AS
Chest; 2005 Jul; 128(1):21-9. PubMed ID: 16002911
[TBL] [Abstract][Full Text] [Related]
7. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
[TBL] [Abstract][Full Text] [Related]
9. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
Maisel AS; McCord J; Nowak RM; Hollander JE; Wu AH; Duc P; Omland T; Storrow AB; Krishnaswamy P; Abraham WT; Clopton P; Steg G; Aumont MC; Westheim A; Knudsen CW; Perez A; Kamin R; Kazanegra R; Herrmann HC; McCullough PA;
J Am Coll Cardiol; 2003 Jun; 41(11):2010-7. PubMed ID: 12798574
[TBL] [Abstract][Full Text] [Related]
10. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
[TBL] [Abstract][Full Text] [Related]
11. Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.
Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Ishihara S; Cohen Solal A; Januzzi JL; Richards AM; Launay JM; Mebazaa A;
Eur Heart J; 2014 Dec; 35(48):3434-41. PubMed ID: 25157115
[TBL] [Abstract][Full Text] [Related]
12. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
[TBL] [Abstract][Full Text] [Related]
13. Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction.
Tate S; Griem A; Durbin-Johnson B; Watt C; Schaefer S
J Biomed Res; 2014 Jul; 28(4):255-61. PubMed ID: 25050108
[TBL] [Abstract][Full Text] [Related]
14. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of tissue Doppler echocardiography in the emergency diagnosis of decompensated heart failure with preserved left ventricular systolic function: comparison with B-type natriuretic peptide measurement.
Arques S; Roux E; Sbragia P; Ambrosi P; Taieb L; Pieri B; Gelisse R; Luccioni R
Echocardiography; 2005 Sep; 22(8):657-64. PubMed ID: 16174119
[TBL] [Abstract][Full Text] [Related]
16. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.
Morrison LK; Harrison A; Krishnaswamy P; Kazanegra R; Clopton P; Maisel A
J Am Coll Cardiol; 2002 Jan; 39(2):202-9. PubMed ID: 11788208
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
18. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department.
McCullough PA; Hollander JE; Nowak RM; Storrow AB; Duc P; Omland T; McCord J; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
Acad Emerg Med; 2003 Mar; 10(3):198-204. PubMed ID: 12615582
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
Bishu K; Deswal A; Chen HH; LeWinter MM; Lewis GD; Semigran MJ; Borlaug BA; McNulty S; Hernandez AF; Braunwald E; Redfield MM
Am Heart J; 2012 Nov; 164(5):763-770.e3. PubMed ID: 23137508
[TBL] [Abstract][Full Text] [Related]
20. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure.
Dokainish H; Zoghbi WA; Lakkis NM; Quinones MA; Nagueh SF
Am J Cardiol; 2004 May; 93(9):1130-5. PubMed ID: 15110205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
